A detailed history of Bridgefront Capital, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Bridgefront Capital, LLC holds 14,196 shares of DXCM stock, worth $1.08 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares
14,196
Holding current value
$1.08 Million
% of portfolio
0.38%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$64.0 - $116.06 $908,544 - $1.65 Million
14,196 New
14,196 $951,000
Q4 2023

Feb 14, 2024

BUY
$75.49 - $124.16 $189,479 - $311,641
2,510 New
2,510 $311,000
Q1 2022

May 13, 2022

SELL
$94.08 - $130.2 $47,322 - $65,490
-503 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$129.87 - $162.82 $65,324 - $81,898
503 New
503 $270,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.5B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Bridgefront Capital, LLC Portfolio

Follow Bridgefront Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgefront Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgefront Capital, LLC with notifications on news.